Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Becciolini

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1992
Post-irradiation hyperamylasemia as a biological dosimeterB Dubray, T Girinski, H D Thames, et al.
Breast Cancer Research and Treatment|December 8, 2000
Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective studyA Volpi, F De Paola, O Nanni, et al.
The European Journal of Surgery = Acta Chirurgica|June 12, 1999
Correlation between DNA content and p53 deletion in colorectal cancerF Cianchi, M Balzi, A Becciolini, et al.
British Journal of Cancer|April 1, 1996
Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomasA J Watson, A J Merritt, L S Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1992
Post-irradiation hyperamylasemia as a biological dosimeterB Dubray, T Girinski, H D Thames, et al.
Breast Cancer Research and Treatment|December 8, 2000
Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective studyA Volpi, F De Paola, O Nanni, et al.
The European Journal of Surgery = Acta Chirurgica|June 12, 1999
Correlation between DNA content and p53 deletion in colorectal cancerF Cianchi, M Balzi, A Becciolini, et al.
British Journal of Cancer|April 1, 1996
Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomasA J Watson, A J Merritt, L S Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Pageof 8